Supernus Pharmaceuticals Inc (SUPN) — Cash Flow-to-Debt Ratio
Supernus Pharmaceuticals Inc (SUPN) has a Cash Flow-to-Debt Ratio of 0.16x as of March 2026, meaning its operating cash flow of $66.52 Million could theoretically repay 0% of its total liabilities ($423.92 Million) in one year. Explore Supernus Pharmaceuticals Inc (SUPN) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Supernus Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Supernus Pharmaceuticals Inc across 18 annual periods. Also explore SUPN total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Supernus Pharmaceuticals Inc (2008–2025)
Year-by-year debt coverage analysis for Supernus Pharmaceuticals Inc. For market capitalisation and broader financial context, see Supernus Pharmaceuticals Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $47.33 Million | $390.93 Million | ▼ -76.6% |
| 2024 | 0.52x | $171.95 Million | $332.34 Million | ▲ +65.9% |
| 2023 | 0.31x | $111.08 Million | $356.16 Million | ▲ +117.9% |
| 2022 | 0.14x | $116.83 Million | $816.30 Million | ▼ -1.7% |
| 2021 | 0.15x | $127.13 Million | $873.30 Million | ▼ -20.1% |
| 2020 | 0.18x | $138.40 Million | $759.24 Million | ▼ -28.1% |
| 2019 | 0.25x | $143.13 Million | $564.85 Million | ▲ +3.1% |
| 2018 | 0.25x | $128.99 Million | $524.79 Million | ▼ -66.3% |
| 2017 | 0.73x | $114.64 Million | $156.98 Million | ▲ +28.8% |
| 2016 | 0.57x | $66.81 Million | $117.81 Million | ▲ +23.3% |
| 2015 | 0.46x | $32.12 Million | $69.86 Million | ▲ +293.4% |
| 2014 | 0.12x | $7.73 Million | $66.15 Million | ▲ +115.6% |
| 2013 | -0.75x | $-57.95 Million | $77.53 Million | ▲ +42.3% |
| 2012 | -1.30x | $-47.20 Million | $36.42 Million | ▼ -58.6% |
| 2011 | -0.82x | $-36.19 Million | $44.29 Million | ▼ -129.3% |
| 2010 | -0.36x | $-32.54 Million | $91.33 Million | ▼ -1264.2% |
| 2009 | 0.03x | $2.63 Million | $86.06 Million | ▲ +108.7% |
| 2008 | -0.35x | $-29.65 Million | $83.88 Million | — |